Fabino Enterprises Ltd
FABINOFabino Enterprises Ltd
FABINOPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 1.36 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
52.29 | 6.68 | 0.47% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Fabino Life Sciences Limited is an India-based pharmaceutical and other wellness focused consumer products company. The Company is engaged in the trading of medicines. It offers you a range of allopathic and herbal products. It is involved in manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other wellness focused consumer products, packing and trading. Its core business is marketing of pharmaceutical formulation and products in domestic market through own distribution network and sales force under own brand name. It exports wellness and fast-moving consumer goods (FMCG) products like coffee, malt powder, protein powder and hair shampoo, which are manufactured and marketed by its company. Its ayurvedic/herbal business operations are supported by loan licensing facilities which are approved by relevant authorities. Its product range is divided into brands, such as Fabino and Keepshine.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2023 | FY 2024 | TTM | |||
---|---|---|---|---|---|---|
Total Revenue | 3.38 | 21.39 | — | |||
Raw Materials | 2.43 | 20.20 | — | |||
Power & Fuel Cost | 0.00 | 0.00 | ||||
Employee Cost | 0.19 | 0.18 | ||||
Selling & Administrative Expenses | 0.16 | 0.25 | ||||
Operating & Other expenses | 0.55 | 0.63 | ||||
EBITDA | 0.05 | 0.13 | — | |||
Depreciation/Amortization | 0.03 | 0.04 | — | |||
PBIT | 0.02 | 0.09 | — | |||
Interest & Other Items | 0.01 | 0.04 | — | |||
PBT | 0.01 | 0.05 | — | |||
Taxes & Other Items | 0.00 | 0.01 | — | |||
Net Income | 0.01 | 0.04 | — | |||
EPS | 0.05 | 0.19 | — | |||
DPS | 0.00 | 0.00 | — | |||
Payout ratio | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Fabino Enterprises Ltd | 140.70 | 1.36 | — |
Sun Pharmaceutical Industries Ltd | 47.65 | 6.80 | 0.71% |
Cipla Ltd | 31.27 | 4.81 | 0.81% |
Torrent Pharmaceuticals Ltd | 71.45 | 17.26 | 0.80% |
Price Comparison
Compare FABINO with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2022
Mar 2023
Sep 2023
Mar 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
FABINO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Fabino Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 16 September 2024.Powered by Capital Market - Live
Fabino Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 16 September 2024.Powered by Capital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant